arrow
L

Linda B. Baughn

Mayo Clinic
H指数:28
被引数:2,992

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Chromosome 1q Gain Defines a Plasma Cell–Dominant Adverse-Risk Subtype in AL Amyloidosis With Inferior Long-Term Survival

1q染色体增益定义了AL淀粉样变性中一种浆细胞占优势的不良风险亚型,其长期生存率较差

2026-08-260
PRE
A multicenter study of progression risk and outcomes in solitary bone plasmacytoma with and without marrow involvement

多中心研究:伴有和不伴有骨髓浸润的孤立性骨浆细胞瘤的进展风险和结局

2026-04-270
OA
A single next generation sequencing assay for detection of driver mutations, rearrangements and copy number abnormalities in plasma cell dyscrasias

一种用于检测浆细胞异常中驱动突变、重排和拷贝数异常的下一代测序检测方法

2026-03-280
OAAI
Multiple myeloma risk linked to DNA damage response genes

多发性骨髓瘤风险与DNA损伤应答基因相关

2026-01-060
OAAI
Genomic profiling reveals molecular heterogeneity in patients with Richter transformation (RT) and chronic lymphocytic leukemia (CLL)

基因组分析揭示了Richter transformation (RT)和chronic lymphocytic leukemia (CLL)患者中的分子异质性。

2025-11-010
OAAI
Temporal genomic dynamics shape clinical trajectory in multiple myeloma

时间基因组动力学塑造多发性骨髓瘤的临床轨迹

2025-08-200
OA
Guidelines for the testing and reporting of cytogenetic results for risk stratification of multiple myeloma: a report of the Cancer Genomics Consortium Plasma Cell Neoplasm Working Group

多发性骨髓瘤风险分层中细胞遗传学结果测试与报告的指南:癌症基因组联盟浆细胞肿瘤工作组报告

2025-06-180
OAAI
Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma.

双等位基因抗原逃逸是抗CD38抗体在多发性骨髓瘤中的一种耐药机制。

Blood
IF23.1
2025-06-160
PRE
The Role of NOXA in Venetoclax Treatment Response in Multiple Myeloma

NOXA在Venetoclax治疗反应中的作用在多发性骨髓瘤中的作用

BLOOD
IF23.1
2024-11-050
PRE
Functional variant rs9344 at 11q13.3 regulates CCND1 expression in multiple myeloma with t(11;14)

11 q13.3的功能变体rs9344调节t(11;14) 多发性骨髓瘤中CCND1的表达

LEUKEMIA
IF13.4
2024-10-140
OAAI
FDA IDE validation of multiple myeloma MRD test by flow cytometry

FDA通过流式细胞仪对多发性骨髓瘤MRD测试的验证

2024-09-180
PRE
Real-life sensitivity of flow cytometry minimal residual disease assessment for plasma cell neoplasms

流式细胞术对浆细胞肿瘤的最小残留病评估的现实敏感性

2024-07-310
OAAI
Family history of plasma cell disorders is associated with improved survival in MGUS, multiple myeloma, and systemic AL amyloidosis (vol 36, pg 1058, 2022)

浆细胞疾病的家族史与MGUS,多发性骨髓瘤和系统性AL淀粉样变性的生存率提高有关 (第36卷,1058页,2022)

LEUKEMIA
IF13.4
2024-06-170
OA